{"id":"tp-55529","type":"article-newspaper","title":"China Approves Eli Lilly’s Orforglipron Weight-Loss Pill","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/55529","datePublished":"2026-11-12T14:50:36.000Z","dateModified":"2026-11-12T14:50:36.000Z","language":"en","abstract":"Lilly is the first drugmaker to receive Chinese clearance for a GLP-1 weight-loss pill, giving it an early lead over Novo Nordisk.","section":"Regulation","references":[{"title":"marketing authorization for Foundayo","url":"https://www.tokenpost.com/news/business/33429"}]}